Synopsis: OBSC Perfection secures Rs 22.6 Cr auto parts deal over 7 years. Stock surges 14% to Rs 317.45 (mcap Rs 772 Cr); 111% 1-yr returns. Domestic stability boost.
OBSC Perfection Limited has secured a major new contract. An Indian auto components manufacturer has issued the company a Nomination Letter worth Rs 22.6 crore. The deal covers the manufacturing and supply of machined parts over a seven-year period.
OBSC Perfection Limited’s stock, with a market capitalisation of Rs. 772 crores, rose Rs. 325, up 14 percent from its previous closing price of Rs. 284.95. Furthermore, the stock over the past year has given a return of 111 percent.
OBSC Perfection will manufacture and supply machined parts for automobiles. The contract is entirely domestic in nature. Both the buyer and the supplier operate within India.
The production rollout happens in two stages. The first phase kicks off in November 2028. The second phase follows in June 2029. Together, they cover an estimated programme life cycle of seven years.
Moreover, long-term contracts like this bring stability to a company’s operations. The seven-year timeline gives OBSC Perfection a reliable revenue stream going forward. Furthermore, a deal of this size signals growing confidence from buyers in the auto sector.
OBSC Perfection Limited, founded in 2017, manufactures precision metal components mainly for India’s automotive sector (91% revenue), plus defense, marine, and telecom.
Part of the Anglian Omega Group, it operates five plants in Pune and Chennai, producing items like shock absorber rods, sensor bosses, and shafts via CNC machining and casting. With Rs 164 crore revenue, Rs 20 Cr profit, Rs 772 Cr market cap, ROE 25%, and 87% 1-year stock growth, it supplies Tier II/III OEMs domestically and exports.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
